Annual ROE
-24.75%
+207.83%+89.36%
December 31, 2023
Summary
- As of February 7, 2025, SLNO annual return on equity is -24.75%, with the most recent change of +207.83% (+89.36%) on December 31, 2023.
- During the last 3 years, SLNO annual ROE has risen by +29.35% (+54.25%).
- SLNO annual ROE is now -120.92% below its all-time high of 118.30%, reached on December 31, 2014.
Performance
SLNO ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-61.99%
-18.74%-43.33%
September 30, 2024
Summary
- As of February 7, 2025, SLNO quarterly return on equity is -61.99%, with the most recent change of -18.74% (-43.33%) on September 30, 2024.
- Over the past year, SLNO quarterly ROE has increased by +210.89% (+77.28%).
- SLNO quarterly ROE is now -116.56% below its all-time high of 374.25%, reached on December 31, 2015.
Performance
SLNO Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
SLNO ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +89.4% | +77.3% |
| 3 y3 years | +54.3% | +77.3% |
| 5 y5 years | +43.6% | +77.3% |
SLNO ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +89.4% | -43.3% | +77.9% |
| 5 y | 5-year | at high | +89.4% | -43.3% | +77.9% |
| alltime | all time | -120.9% | +95.0% | -116.6% | +99.7% |
Soleno Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -61.99%(+43.3%) |
| Jun 2024 | - | -43.25%(-30.1%) |
| Mar 2024 | - | -61.84%(-22.4%) |
| Dec 2023 | -24.75%(-89.4%) | -79.65%(-70.8%) |
| Sep 2023 | - | -272.88%(-2.6%) |
| Jun 2023 | - | -280.20%(+27.2%) |
| Mar 2023 | - | -220.22%(+65.4%) |
| Dec 2022 | -232.58%(+33.9%) | -133.12%(+24.0%) |
| Sep 2022 | - | -107.36%(-2.8%) |
| Jun 2022 | - | -110.50%(-8.3%) |
| Mar 2022 | - | -120.49%(+0.4%) |
| Dec 2021 | -173.72%(+221.1%) | -120.04%(+26.9%) |
| Sep 2021 | - | -94.63%(+19.7%) |
| Jun 2021 | - | -79.06%(+33.5%) |
| Mar 2021 | - | -59.23%(-4.3%) |
| Dec 2020 | -54.10%(-73.7%) | -61.90%(-45.3%) |
| Sep 2020 | - | -113.25%(+0.2%) |
| Jun 2020 | - | -113.01%(-49.3%) |
| Mar 2020 | - | -222.76%(+21.8%) |
| Dec 2019 | -205.89% | -182.89%(+138.2%) |
| Sep 2019 | - | -76.77%(-19.2%) |
| Jun 2019 | - | -95.07%(+20.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -78.78%(+23.3%) |
| Dec 2018 | -43.85%(-23.6%) | -63.90%(-30.4%) |
| Sep 2018 | - | -91.85%(+5.2%) |
| Jun 2018 | - | -87.27%(+33.5%) |
| Mar 2018 | - | -65.38%(+13.5%) |
| Dec 2017 | -57.37%(-84.2%) | -57.59%(-9.3%) |
| Sep 2017 | - | -63.52%(-14.3%) |
| Jun 2017 | - | -74.08%(-34.0%) |
| Mar 2017 | - | -112.29%(-59.1%) |
| Dec 2016 | -362.37%(-26.6%) | -274.35%(-3.1%) |
| Sep 2016 | - | -283.01%(-87.9%) |
| Jun 2016 | - | -2338.87%(-89.4%) |
| Mar 2016 | - | -22.09 K%(-6003.4%) |
| Dec 2015 | -493.47%(-517.1%) | 374.25%(+44.9%) |
| Sep 2015 | - | 258.23%(+141.5%) |
| Jun 2015 | - | 106.93%(+16.7%) |
| Mar 2015 | - | 91.64%(+129.1%) |
| Dec 2014 | 118.30%(+1108.4%) | 40.00%(+127.4%) |
| Sep 2014 | - | 17.59%(+10.5%) |
| Jun 2014 | - | 15.92%(+9.7%) |
| Mar 2014 | - | 14.51%(+48.2%) |
| Dec 2013 | 9.79%(-48.4%) | 9.79% |
| Dec 2012 | 18.96% | - |
FAQ
- What is Soleno Therapeutics annual return on equity?
- What is the all time high annual ROE for Soleno Therapeutics?
- What is Soleno Therapeutics annual ROE year-on-year change?
- What is Soleno Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Soleno Therapeutics?
- What is Soleno Therapeutics quarterly ROE year-on-year change?
What is Soleno Therapeutics annual return on equity?
The current annual ROE of SLNO is -24.75%
What is the all time high annual ROE for Soleno Therapeutics?
Soleno Therapeutics all-time high annual return on equity is 118.30%
What is Soleno Therapeutics annual ROE year-on-year change?
Over the past year, SLNO annual return on equity has changed by +207.83% (+89.36%)
What is Soleno Therapeutics quarterly return on equity?
The current quarterly ROE of SLNO is -61.99%
What is the all time high quarterly ROE for Soleno Therapeutics?
Soleno Therapeutics all-time high quarterly return on equity is 374.25%
What is Soleno Therapeutics quarterly ROE year-on-year change?
Over the past year, SLNO quarterly return on equity has changed by +210.89% (+77.28%)